Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:03 AM
Ignite Modification Date:
2025-12-25 @ 12:03 AM
NCT ID:
NCT02838758
Eligibility Criteria:
Inclusion Criteria:
* Between the ages of 18 and 80 years old
* Magnetic Resonance Imaging (MRI) confirmed diagnosis of Morton's neuroma - Refractory (greater than 3 month) symptoms to multiple conservative management, including physical therapy, nonsteroidal anti-inflammatory drugs (NSAIDS) and foot orthotics.
* No history of systemic inflammatory conditions such as rheumatoid arthritis
* Able to give written informed consent - Subject has been on a stable dose of analgesic mediation (or not on analgesic medication) for at least 3 weeks and is agreeable to remaining on current regimen for the duration of the study.
Exclusion Criteria:
* Diagnosed complex regional pain syndrome (CRPS)
* Pregnancy - History of intolerance, hypersensitivity or known allergy to lidocaine - Recent history of recent surgical intermetatarsal neuronectomy (within previous 6 months) - Coagulation disorder - Current infection
* Intermetatarsal bursitis
* Metatarsophalangeal joint instability/capsulitis
* Metatarsal stress fracture
* Lumbar radiculopathy
* Tarsal tunnel syndrome
* Frieberg's infraction
* Painful callosities associated with toe deformities
* Peripheral neuropathy
* Diabetes mellitus and peripheral vascular diseases
* Insufficient command of English to complete self-¬report instruments.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT02838758
Study Brief:
Protocol Section:
NCT02838758